|
MAY
29
|
Unraveling Cancer One Base at a Time
Focus: Cancer
Leeds, United Kingdom
More Info +
Join us to see the latest progress in the study of cancer. Learn how Illumina sequencing and microarray technologies are helping to drive new discoveries for the disease. Illumina solutions allow you to rapidly analyse a patient’s unique cancer genome, epigenome, and transcriptome to elucidate the mechanisms underlying the disease, evaluate potential treatments, and even predict the risk of relapse
In this seminar, you will learn:
- Detect cancer-associated gene mutations with whole-genome sequencing, exome sequencing, or sequencing targeted gene panels
- Detect chromosomal rearrangements and copy number variants
- Characterise epigenetic changes and DNA methylation patterns
- Profile differences in expression levels of normal, mutated, and fusion transcripts between tumor and normal tissues
- Determine the role of small and other non-coding RNAs in cancer biology
Register today, space is limited.
|
Register
|
|
MAY
30
|
Unraveling Cancer One Base at a Time
Focus: Cancer
Stockholm, Sweden
More Info +
Join us to see the latest progress in the study of cancer. Learn how Illumina sequencing and microarray technologies are helping to drive new discoveries for the disease. Illumina solutions allow you to rapidly analyse a patient’s unique cancer genome, epigenome, and transcriptome to elucidate the mechanisms underlying the disease, evaluate potential treatments, and even predict the risk of relapse
In this seminar, you will learn:
- Detect cancer-associated gene mutations with whole-genome sequencing, exome sequencing, or sequencing targeted gene panels
- Detect chromosomal rearrangements and copy number variants
- Characterise epigenetic changes and DNA methylation patterns
- Profile differences in expression levels of normal, mutated, and fusion transcripts between tumor and normal tissues
- Determine the role of small and other non-coding RNAs in cancer biology
Register today, space is limited.
|
Register
|
|
MAY
30
|
Using Illumina Next-Generation Sequencing Technology to Study Microbial Genetics
Focus: Microbiology
Stockholm, Sweden
More Info +
Accurate microorganism identification and characterization are essential for disease diagnosis, microbial outbreak profiling, and environmental community studies. In the last two decades, many molecular tools have been developed for determining objective standards for microorganism characterization and identification. Illumina next-generation sequencing technology has revolutionized microbiology studies, enabling high resolution genomic and transcriptomic analyses.
In this seminar, you will learn about:
- Illumina sequencing approaches for bacterial strain identification and characterization.
- High-throughput analysis to estimate microbial community diversity.
- Bacterial and viral detection and characterization through academic and clinical examples.
Register today, space is limited.
|
Register
|
|
JUN
04
|
Unraveling Cancer One Base at a Time
Focus: Cancer
Umeå, Sweden
More Info +
Join us to see the latest progress in the study of cancer. Learn how Illumina sequencing and microarray technologies are helping to drive new discoveries for the disease. Illumina solutions allow you to rapidly analyse a patient’s unique cancer genome, epigenome, and transcriptome to elucidate the mechanisms underlying the disease, evaluate potential treatments, and even predict the risk of relapse.
In this seminar, you will learn:
- Detect cancer-associated gene mutations with whole-genome sequencing, exome sequencing, or sequencing targeted gene panels
- Detect chromosomal rearrangements and copy number variants
- Characterise epigenetic changes and DNA methylation patterns
- Profile differences in expression levels of normal, mutated, and fusion transcripts between tumor and normal tissues
- Determine the role of small and other non-coding RNAs in cancer biology
Register today, space is limited.
|
Register
|
|
JUN
05
|
Empowering New Discoveries through Next-Generation Sequencing
Focus: Sequencing Portfolio
Gothenburg, Sweden
More Info +
Discover how next-generation sequencing can help you unlock new discoveries to drive your research forward. Backed by over 2,300 peer-reviewed publications, Illumina’s proven sequencing by synthesis technology delivers rapid, highly accurate results. All with the simplest integrated experimental workflow available. The technology is fuelling new advancements in many biological areas, allowing researchers to look at the genome, transcriptome, and epigenome with a resolution like never before.
In this seminar, learn about
- A broad range of sequencing applications, including mutation and variant discovery, chromatin immunoprecipitation (ChIP-Seq), transcriptome profiling, and noncoding RNA discovery
- Sequencing studies for any sample type or species, including human, animal, plant, or microbial
- The MiSeq® personal sequencer, ideal for small genomes, small RNA, targeted resequencing of up 36,864 amplicons in a single run, and much more
- The new HiSeq® 2500 system, capable of sequencing an entire human genome in about 24 hours—a “Genome in a Day”
Register today, space is limited.
|
Register
|
|
JUN
05
|
Using Illumina Next-Generation Sequencing Technology to Study Microbial Genetics
Focus: Microbiology
Antwerp, Belgium
More Info +
Accurate microorganism identification and characterization are essential for disease diagnosis, microbial outbreak profiling, and environmental community studies. In the last two decades, many molecular tools have been developed for determining objective standards for microorganism characterization and identification. Illumina next-generation sequencing technology has revolutionized microbiology studies, enabling high resolution genomic and transcriptomic analyses.
In this seminar, you will learn about:
- Illumina sequencing approaches for bacterial strain identification and characterization.
- High-throughput analysis to estimate microbial community diversity.
- Bacterial and viral detection and characterization through academic and clinical examples.
Register today, space is limited.
|
Register
|
|
JUN
05
|
Unraveling Cancer One Base at a Time
Focus: Cancer
Antwerp, Belgium
More Info +
Join us to see the latest progress in the study of cancer. Learn how Illumina sequencing and microarray technologies are helping to drive new discoveries for the disease. Illumina solutions allow you to rapidly analyse a patient’s unique cancer genome, epigenome, and transcriptome to elucidate the mechanisms underlying the disease, evaluate potential treatments, and even predict the risk of relapse.
In this seminar, you will learn:
- Detect cancer-associated gene mutations with whole-genome sequencing, exome sequencing, or sequencing targeted gene panels
- Detect chromosomal rearrangements and copy number variants
- Characterise epigenetic changes and DNA methylation patterns
- Profile differences in expression levels of normal, mutated, and fusion transcripts between tumor and normal tissues
- Determine the role of small and other non-coding RNAs in cancer biology
Register today, space is limited.
|
Register
|
|
JUN
07
|
Unraveling Cancer One Base at a Time
Focus: Cancer
Amsterdam, Netherlands
More Info +
Join us to see the latest progress in the study of cancer. Learn how Illumina sequencing and microarray technologies are helping to drive new discoveries for the disease. Illumina solutions allow you to rapidly analyse a patient’s unique cancer genome, epigenome, and transcriptome to elucidate the mechanisms underlying the disease, evaluate potential treatments, and even predict the risk of relapse.
In this seminar, you will learn:
- Detect cancer-associated gene mutations with whole-genome sequencing, exome sequencing, or sequencing targeted gene panels
- Detect chromosomal rearrangements and copy number variants
- Characterise epigenetic changes and DNA methylation patterns
- Profile differences in expression levels of normal, mutated, and fusion transcripts between tumor and normal tissues
- Determine the role of small and other non-coding RNAs in cancer biology
Register today, space is limited.
|
Register
|
|
JUN
07
|
Empowering New Discoveries through Next-Generation Sequencing
Focus: Sequencing Portfolio
Amsterdam, Netherlands
More Info +
Discover how next-generation sequencing can help you unlock new discoveries to drive your research forward. Backed by over 2,300 peer-reviewed publications, Illumina’s proven sequencing by synthesis technology delivers rapid, highly accurate results. All with the simplest integrated experimental workflow available. The technology is fuelling new advancements in many biological areas, allowing researchers to look at the genome, transcriptome, and epigenome with a resolution like never before.
In this seminar, learn about
- A broad range of sequencing applications, including mutation and variant discovery, chromatin immunoprecipitation (ChIP-Seq), transcriptome profiling, and noncoding RNA discovery
- Sequencing studies for any sample type or species, including human, animal, plant, or microbial
- The MiSeq® personal sequencer, ideal for small genomes, small RNA, targeted resequencing of up 36,864 amplicons in a single run, and much more
- The new HiSeq® 2500 system, capable of sequencing an entire human genome in about 24 hours—a “Genome in a Day”
Register today, space is limited.
|
Register
|
|
JUN
12
|
Empowering New Discoveries through Next-Generation Sequencing
Focus: Sequencing Portfolio
Nantes, France
More Info +
Discover how next-generation sequencing can help you unlock new discoveries to drive your research forward. Backed by over 2,300 peer-reviewed publications, Illumina’s proven sequencing by synthesis technology delivers rapid, highly accurate results. All with the simplest integrated experimental workflow available. The technology is fuelling new advancements in many biological areas, allowing researchers to look at the genome, transcriptome, and epigenome with a resolution like never before.
In this seminar, learn about
- A broad range of sequencing applications, including mutation and variant discovery, chromatin immunoprecipitation (ChIP-Seq), transcriptome profiling, and noncoding RNA discovery
- Sequencing studies for any sample type or species, including human, animal, plant, or microbial
- The MiSeq® personal sequencer, ideal for small genomes, small RNA, targeted resequencing of up 36,864 amplicons in a single run, and much more
- The new HiSeq® 2500 system, capable of sequencing an entire human genome in about 24 hours—a “Genome in a Day”
Register today, space is limited.
|
Register
|
|
JUN
12
|
Using Illumina Next-Generation Sequencing Technology to Study Microbial Genetics
Focus: Microbiology
Hamburg, Germany
More Info +
Accurate microorganism identification and characterization are essential for disease diagnosis, microbial outbreak profiling, and environmental community studies. In the last two decades, many molecular tools have been developed for determining objective standards for microorganism characterization and identification. Illumina next-generation sequencing technology has revolutionized microbiology studies, enabling high resolution genomic and transcriptomic analyses.
In this seminar, you will learn about:
- Illumina sequencing approaches for bacterial strain identification and characterization.
- High-throughput analysis to estimate microbial community diversity.
- Bacterial and viral detection and characterization through academic and clinical examples.
Register today, space is limited.
|
Register
|
|
JUN
13
|
Empowering New Discoveries through Next-Generation Sequencing
Focus: Sequencing Portfolio
Aberdeen, United Kingdom
More Info +
Discover how next-generation sequencing can help you unlock new discoveries to drive your research forward. Backed by over 2,300 peer-reviewed publications, Illumina’s proven sequencing by synthesis technology delivers rapid, highly accurate results. All with the simplest integrated experimental workflow available. The technology is fuelling new advancements in many biological areas, allowing researchers to look at the genome, transcriptome, and epigenome with a resolution like never before.
In this seminar, learn about
- A broad range of sequencing applications, including mutation and variant discovery, chromatin immunoprecipitation (ChIP-Seq), transcriptome profiling, and noncoding RNA discovery
- Sequencing studies for any sample type or species, including human, animal, plant, or microbial
- The MiSeq® personal sequencer, ideal for small genomes, small RNA, targeted resequencing of up 36,864 amplicons in a single run, and much more
- The new HiSeq® 2500 system, capable of sequencing an entire human genome in about 24 hours—a “Genome in a Day”
Register today, space is limited.
|
Register
|
|
JUN
15
|
Unraveling Cancer One Base at a Time
Focus: Cancer
Rotterdam, Netherlands
More Info +
Join us to see the latest progress in the study of cancer. Learn how Illumina sequencing and microarray technologies are helping to drive new discoveries for the disease. Illumina solutions allow you to rapidly analyse a patient’s unique cancer genome, epigenome, and transcriptome to elucidate the mechanisms underlying the disease, evaluate potential treatments, and even predict the risk of relapse.
In this seminar, you will learn:
- Detect cancer-associated gene mutations with whole-genome sequencing, exome sequencing, or sequencing targeted gene panels
- Detect chromosomal rearrangements and copy number variants
- Characterise epigenetic changes and DNA methylation patterns
- Profile differences in expression levels of normal, mutated, and fusion transcripts between tumor and normal tissues
- Determine the role of small and other non-coding RNAs in cancer biology
Register today, space is limited.
|
Register
|
|
JUN
15
|
Using Illumina Next-Generation Sequencing Technology to Study Microbial Genetics
Focus: Microbiology
Rotterdam, Netherlands
More Info +
Accurate microorganism identification and characterization are essential for disease diagnosis, microbial outbreak profiling, and environmental community studies. In the last two decades, many molecular tools have been developed for determining objective standards for microorganism characterization and identification. Illumina next-generation sequencing technology has revolutionized microbiology studies, enabling high resolution genomic and transcriptomic analyses.
In this seminar, you will learn about:
- Illumina sequencing approaches for bacterial strain identification and characterization.
- High-throughput analysis to estimate microbial community diversity.
- Bacterial and viral detection and characterization through academic and clinical examples.
Register today, space is limited.
|
Register
|
|
JUL
04
|
Empowering New Discoveries through Next-Generation Sequencing
Focus: Sequencing Portfolio
Munich, Germany
More Info +
Discover how next-generation sequencing can help you unlock new discoveries to drive your research forward. Backed by over 2,300 peer-reviewed publications, Illumina’s proven sequencing by synthesis technology delivers rapid, highly accurate results. All with the simplest integrated experimental workflow available. The technology is fuelling new advancements in many biological areas, allowing researchers to look at the genome, transcriptome, and epigenome with a resolution like never before.
In this seminar, learn about
- A broad range of sequencing applications, including mutation and variant discovery, chromatin immunoprecipitation (ChIP-Seq), transcriptome profiling, and noncoding RNA discovery
- Sequencing studies for any sample type or species, including human, animal, plant, or microbial
- The MiSeq® personal sequencer, ideal for small genomes, small RNA, targeted resequencing of up 36,864 amplicons in a single run, and much more
- The new HiSeq® 2500 system, capable of sequencing an entire human genome in about 24 hours—a “Genome in a Day”
Register today, space is limited.
|
Register
|
|
JUL
05
|
Unraveling Cancer One Base at a Time
Focus: Cancer
Heidelberg, Germany
More Info +
Join us to see the latest progress in the study of cancer. Learn how Illumina sequencing and microarray technologies are helping to drive new discoveries for the disease. Illumina solutions allow you to rapidly analyse a patient’s unique cancer genome, epigenome, and transcriptome to elucidate the mechanisms underlying the disease, evaluate potential treatments, and even predict the risk of relapse.
In this seminar, you will learn:
- Detect cancer-associated gene mutations with whole-genome sequencing, exome sequencing, or sequencing targeted gene panels
- Detect chromosomal rearrangements and copy number variants
- Characterise epigenetic changes and DNA methylation patterns
- Profile differences in expression levels of normal, mutated, and fusion transcripts between tumor and normal tissues
- Determine the role of small and other non-coding RNAs in cancer biology
Register today, space is limited.
|
Register
|
|
JUL
10
|
Using Illumina Next-Generation Sequencing Technology to Study Microbial Genetics
Focus: Microbiology
Oxford, United Kingdom
More Info +
Accurate microorganism identification and characterization are essential for disease diagnosis, microbial outbreak profiling, and environmental community studies. In the last two decades, many molecular tools have been developed for determining objective standards for microorganism characterization and identification. Illumina next-generation sequencing technology has revolutionized microbiology studies, enabling high resolution genomic and transcriptomic analyses.
In this seminar, you will learn about:
- Illumina sequencing approaches for bacterial strain identification and characterization.
- High-throughput analysis to estimate microbial community diversity.
- Bacterial and viral detection and characterization through academic and clinical examples.
Register today, space is limited.
|
Register
|
|
JUL
11
|
Unraveling Cancer One Base at a Time
Focus: Cancer
Barcelona, Spain
More Info +
Join us to see the latest progress in the study of cancer. Learn how Illumina sequencing and microarray technologies are helping to drive new discoveries for the disease. Illumina solutions allow you to rapidly analyse a patient’s unique cancer genome, epigenome, and transcriptome to elucidate the mechanisms underlying the disease, evaluate potential treatments, and even predict the risk of relapse.
In this seminar, you will learn:
- Detect cancer-associated gene mutations with whole-genome sequencing, exome sequencing, or sequencing targeted gene panels
- Detect chromosomal rearrangements and copy number variants
- Characterise epigenetic changes and DNA methylation patterns
- Profile differences in expression levels of normal, mutated, and fusion transcripts between tumor and normal tissues
- Determine the role of small and other non-coding RNAs in cancer biology
Register today, space is limited.
|
Register
|
|
JUL
12
|
Unraveling Cancer One Base at a Time
Focus: Cancer
Madrid, Spain
More Info +
Join us to see the latest progress in the study of cancer. Learn how Illumina sequencing and microarray technologies are helping to drive new discoveries for the disease. Illumina solutions allow you to rapidly analyse a patient’s unique cancer genome, epigenome, and transcriptome to elucidate the mechanisms underlying the disease, evaluate potential treatments, and even predict the risk of relapse.
In this seminar, you will learn:
- Detect cancer-associated gene mutations with whole-genome sequencing, exome sequencing, or sequencing targeted gene panels
- Detect chromosomal rearrangements and copy number variants
- Characterise epigenetic changes and DNA methylation patterns
- Profile differences in expression levels of normal, mutated, and fusion transcripts between tumor and normal tissues
- Determine the role of small and other non-coding RNAs in cancer biology
Register today, space is limited.
|
Register
|
